Skip to main content

Table 1 Baseline characteristics among patients being prescribed DOACs

From: Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration

Patient Characteristics

All n = 2882

Dabigatran n = 2096 (72.7%)

Rivaroxaban n = 571 (19.8%)

Apixaban n = 215 (7.5%)

p

Age (mean + SD)

67.4 (9.5)

66.9 (9.3)

67.3 (9.7)

73.1 (8.8)

<0.01

Male (%)

2792 (96.9)

2035 (97.1)

552 (96.7)

205 (95.4)

0.32

White Race (%)

2383 (82.7)

1735 (82.8)

467 (81.8)

181 (84.2)

0.72

Hypertension (%)

2556 (88.7)

1874 (89.4)

503 (88.1)

179 (83.3)

0.03

Congestive Heart Failure (%)

852 (29.6)

624 (29.8)

173 (30.3)

55 (25.6)

0.41

Diabetes Mellitus (%)

1398 (48.5)

1036 (49.4)

270 (47.3)

92 (42.8)

0.15

Cerebrovascular Accident (%)

321 (11.1)

240 (11.5)

63 (11.0)

18 (8.4)

0.41

Prior Myocardial Infarction (%)

391 (13.6)

269 (12.8)

89 (15.6)

33 (15.4)

0.16

Peripheral Arterial Disease (%)

280 (9.7)

201 (9.6)

53 (9.3)

26 (12.1)

0.45

Peripheral Arterial Disease (%)

2.9 (1.1)

2.9 (1.0)

3.0 (1.1)

3.2 (1.2)

<0.01

CHA2DS2-VASc (mean + SD)

2.9 (1.1)

2.9 (1.0)

3.0 (1.1)

3.2 (1.2)

<0.01

Adherence

 Mean (SD) pill count per dispensed supply

38.1 (20.9)

38.2 (20.8)

38.2 (22.0)

36.4 (18.7)

<0.01

 Proportion of Days Covered (mean + SD)

0.85 (0.19)

0.84 (0.20)

0.86 (0.18)

0.89 (0.14)

<0.01

 PDC < 80% n (%)

796 (27.6%)

604 (28.8%)

143 (25.0%)

49 (22.8%)

0.05